Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)

T/myeloid mixed-phenotype acute leukemia not otherwise specified (MPAL NOS) is an uncommon and aggressive leukemia without well-established treatment guidelines, particularly when relapsed. Venetoclax plus a hypomethylating agent offers a promising option in this situation since studies support its...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Hematol
Main Authors: Klocke, Heather, Dong, Zhao Ming, O'Brien, Craig, Burwick, Nicholas, Richard, Robert E., Wu, Daniel Y., Chauncey, Thomas R., Graf, Solomon A.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569429/
https://ncbi.nlm.nih.gov/pubmed/33101740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8811673
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki